Zevra’s Miplyffa Wins First-Ever US Approval, But In Combination With Off-Label Miglustat

Drug’s List Price Is $1m Per Year On Average

 
• By Mandy Jackson
  
Start your own business, launch success rocket or entrepreneur, startup project or boost company growth, invention concept, ambitious businessman entrepreneur push switch to launch rocket into sky.
Zevra will pull the lever on its Miplyffa launch in eight to 12 weeks • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip